Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid vs Lyophilized GBS Trivalent Vaccine in Healthy Women
NCT02270944Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Split/Subunit Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of group b streptococcus trivalent vaccine in group B streptococcal infection, sponsored by GSK. Started Nov 2014; status: completed.
02
Drugs
group b streptococcus trivalent vaccine
03
Conditions
group B streptococcal infection
Beyond the preview
Go deeper on NCT02270944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02270944.